PuSH - Publikationsserver des Helmholtz Zentrums München

Stemberger, C.* ; Graef, P.* ; Odendahl, M.* ; Albrecht, J. ; Doessinger, G.* ; Anderl, F.* ; Buchholz, V.R.* ; Gasteiger, G. ; Schiemann, M. ; Grigoleit, G.U.* ; Schuster, F.R.* ; Borkhardt, A.* ; Versluys, B.* ; Tonn, T.* ; Seifried, E.* ; Einsele, H.* ; Germeroth, L.* ; Busch, D.H. ; Neuenhahn, M.

Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy.

Blood 124, 628-637 (2014)
Postprint DOI PMC
Open Access Green
Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are threatened by potentially lethal viral manifestations like cytomegalovirus (CMV) reactivation. Because the success of today's virostatic treatment is limited by side effects and resistance development, adoptive transfer of virus-specific memory T cells derived from the stem cell donor has been proposed as an alternative therapeutic strategy. In this context, dose minimization of adoptively transferred T cells might be warranted for the avoidance of graft-versus-host disease (GVHD), in particular in prophylactic settings after T-cell-depleting allo-HSCT protocols. To establish a lower limit for successful adoptive T-cell therapy, we conducted low-dose CD8(+) T-cell transfers in the well-established murine Listeria monocytogenes (L.m.) infection model. Major histocompatibility complex-Streptamer-enriched antigen-specific CD62L(hi) but not CD62L(io) CD8(+) memory T cells proliferated, differentiated, and protected against L.m. infections after prophylactic application. Even progenies derived from a single CD62L(hi) L.m.-specific CD8(+) T cell could be protective against bacterial challenge. In analogy, low-dose transfers of Streptamer-enriched human CMV-specific CD8(+) T cells into allo-HSCT recipients led to strong pathogen-specific T-cell expansion in a compassionate-use setting. In summary, low-dose adoptive T-cell transfer (ACT) could be a promising strategy, particularly for prophylactic treatment of infectious complications after allo-HSCT.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Versus-host-disease; Cd8-alpha(+) Dendritic Cells; Acute Myeloid-leukemia; Listeria-monocytogenes; Complete Remission; Bone-marrow; In-vivo; Memory; Transplantation; Cytomegalovirus
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Zeitschrift Blood
Quellenangaben Band: 124, Heft: 4, Seiten: 628-637 Artikelnummer: , Supplement: ,
Verlag American Society of Hematology
Verlagsort Washington
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Immunology (IMI)
Institute of Virology (VIRO)